
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **LYZ (Lysozyme):** An enzyme that breaks down bacterial cell walls, commonly associated with myeloid cells, particularly macrophages and neutrophils.<br>- **TYROBP (DAP12):** An adaptor protein involved in immune signaling, often found in myeloid cells.<br>- **AIF1 (Allograft Inflammatory Factor 1):** Involved in inflammatory responses, typically expressed in macrophages and microglia.<br>- **HLA-DRA, HLA-DPA1, HLA-DQA1, HLA-DPB1, HLA-DRB1, HLA-DQB1, HLA-DRB5, HLA-DMA, HLA-DMB:** These are major histocompatibility complex (MHC) class II molecules, crucial for antigen presentation, predominantly expressed in antigen-presenting cells like dendritic cells, macrophages, and B cells.<br>- **FCER1G, FCGR3A, FCGR2A:** Fc receptors involved in binding antibodies, typically found in myeloid cells.<br>- **C1QA, C1QB, C1QC:** Components of the complement system, often associated with macrophages.<br>- **CD14, CD68:** Classical markers for monocytes and macrophages.<br>- **APOE (Apolipoprotein E):** Involved in lipid metabolism, expressed in macrophages and other cell types.<br>- **SPI1 (PU.1):** A transcription factor critical for myeloid and lymphoid lineage development.<br><br>### Step 2: List the Key Cell Type Markers<br>- **CD14, CD68:** Strongly indicative of monocytes and macrophages.<br>- **HLA-DRA, HLA-DPA1, HLA-DQA1, HLA-DPB1, HLA-DRB1, HLA-DQB1, HLA-DRB5, HLA-DMA, HLA-DMB:** Indicate antigen-presenting cells, such as macrophages and dendritic cells.<br>- **LYZ, TYROBP, AIF1:** Commonly associated with myeloid lineage, particularly macrophages.<br>- **C1QA, C1QB, C1QC:** Suggestive of macrophage activity.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Cell Atlas and literature on breast cancer tissue, the expression of these markers is consistent with myeloid lineage cells, particularly macrophages. The presence of MHC class II molecules and complement components further supports this.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of these markers, the most likely general cell type is **macrophages**. These cells are known for their role in immune response, antigen presentation, and tissue homeostasis.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Tumor-associated macrophages (TAMs):** Given the breast cancer tissue context, TAMs are highly probable. They are known to express many of the markers listed, including CD68, CD14, and MHC class II molecules.<br>2. **Classical macrophages (M1):** Characterized by high expression of MHC class II molecules and pro-inflammatory markers.<br>3. **Non-classical macrophages (M2):** Often involved in tissue repair and express markers like CD68 and MHC class II, but with a different cytokine profile.<br><br>The most likely subtype, considering the tumor environment, is **Tumor-associated macrophages (TAMs)**, as they are prevalent in cancer tissues and express a wide range of the provided markers.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of macrophages, specifically tumor-associated macrophages (TAMs). This conclusion is based on the high expression of myeloid and macrophage-specific markers, including CD14, CD68, and MHC class II molecules, which are characteristic of TAMs in the tumor microenvironment.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The markers used in the annotation (e.g., LYZ, TYROBP, AIF1, HLA-DRA, CD14, CD68, etc.) are present in the provided marker list.<br>   - The markers are consistent with the identification of myeloid lineage cells, particularly macrophages. The presence of MHC class II molecules and complement components further supports this.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The analysis does not strongly suggest the presence of multiple distinct cell types. The markers predominantly indicate macrophages, specifically tumor-associated macrophages (TAMs), which are common in breast cancer tissue.<br>   - There is no strong evidence of mixed cell types that would require further investigation.<br><br>The annotation of the cell cluster as macrophages, particularly tumor-associated macrophages (TAMs), is well-supported by the marker list and the context of breast cancer tissue.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">macrophages</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Tumor-associated macrophages (TAMs)</li><li>Classical macrophages (M1)</li><li>Non-classical macrophages (M2)</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided for the single-cell RNA sequencing dataset from breast cancer tissue are generally well-executed, with a strong focus on identifying macrophages, particularly tumor-associated macrophages (TAMs). Here are the key points of evaluation:<br><br>1. **Correctness of Annotations:**<br>   - The annotation correctly identifies macrophages as the main cell type, which is consistent with the marker list provided. Markers such as CD14, CD68, and various MHC class II molecules are classic indicators of macrophages, and their presence in the dataset supports this classification.<br>   - The identification of TAMs as the most probable subtype is appropriate given the context of breast cancer tissue, where TAMs are known to play a significant role in the tumor microenvironment.<br><br>2. **Balanced Consideration of Multiple Markers:**<br>   - The analysis effectively considers a wide range of markers, including those related to myeloid lineage (e.g., LYZ, TYROBP, AIF1) and antigen presentation (e.g., HLA-DRA, HLA-DPA1). This balanced approach ensures that the annotation is not overly reliant on a single marker but rather considers the collective expression profile.<br>   - The annotation history demonstrates a systematic approach to marker evaluation, listing key functional and cell type markers, which helps in forming a comprehensive view of the cell population.<br><br>3. **Ability to Capture the General Picture:**<br>   - The annotation captures the general picture of the cell populations by focusing on macrophages and their subtypes, which are relevant to the breast cancer context. The inclusion of both classical (M1) and non-classical (M2) macrophages as potential subtypes further enriches the understanding of the cell population dynamics.<br>   - The analysis does not indicate the presence of mixed cell types, which seems reasonable given the strong macrophage signature in the marker list. However, a brief consideration of potential other cell types could have been beneficial to ensure no significant populations were overlooked.<br><br>4. **Consideration of Marker Rank:**<br>   - The annotation does not explicitly discuss the rank or importance of markers based on their position in the list. While the analysis is thorough, acknowledging the rank of markers could provide additional insights into their relative importance in defining the cell type.<br><br>Overall, the annotation is scientifically accurate, well-balanced in marker usage, and provides a comprehensive view of the cell types present. There are no obvious misclassifications, and the focus on TAMs is justified by the context. However, a slight improvement could be made by considering the rank of markers and briefly exploring the possibility of other cell types.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    